FDA Grants Traditional Approval to First Complement Inhibitor for Primary IgA Nephropathy

FDA approves Alecensa as first adjuvant treatment for people... MedEdge MEA

Basel- April 2024- Roche announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumour resection f...

Read More
Roche’s Xolair Nears FDA Approval for Multiple Food Allergy Reduction MedEdge MEA

Basel, Switzerland- Roche is one step closer to gaining FDA approval for Xolair® (omalizumab). The agency accepts its supplemental Biologics License Application (sBLA) un...

Read More
Menu
Categories
How does it work